⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL36713 | 1.00 | — | — | |
| SCHEMBL2322217 | 1.00 | — | — | |
| SCHEMBL4476955 | 0.78 | SMN1; SMN2 (0.41) | — | |
| SCHEMBL690839 | 0.78 | SMN1; SMN2 (0.48) | — | |
| SCHEMBL5434607 | 0.78 | SMN1; SMN2 (0.32) | — | |
| SCHEMBL2007852 | 0.78 | — | — | |
| SCHEMBL952339 | 0.78 | SMN1; SMN2 (0.32) | — | |
| SCHEMBL482543 | 0.78 | — | — | |
| SCHEMBL1415223 | 0.78 | SMN1; SMN2 (0.48) | — | |
| SCHEMBL17068140 | 0.78 | SMN1; SMN2 (0.48) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116621697-A | Preparation method of dextrorotation 2- (2, 4-dichlorophenoxy) propionic acid | 南京工业大学 | 2023-08-22 | — | — | CN | claimed |
| CN-112694403-B | Method for preparing (R) - (+) -2- (4-hydroxyphenoxy) methyl propionate | 锦州三丰科技有限公司 | 2023-04-18 | — | — | CN | claimed |
| CN-112812002-B | Preparation method of (R) - (+) -2- (4-hydroxyphenoxy) propionic acid | 锦州三丰科技有限公司 | 2022-12-09 | — | — | CN | claimed |
| EP-4648762-A2 | PPARG MODULATORS | University of Florida Research Foundation, Incorporated (US) | 2025-11-19 | — | — | EP | disclosed |
| US-20250325550-A1 | HETEROCYCLYLAMINES AS PI3K INHIBITORS | INCYTE CORP (US) | 2025-10-23 | — | — | US | disclosed |
| US-20250289823-A1 | USE OF PYRAZOLOPYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PI3K-DELTA RELATED DISORDERS | INCYTE CORPORATION | 2025-09-18 | — | — | US | disclosed |
| EP-3888657-B1 | HETEROCYCLYLAMINES AS PI3K INHIBITORS | INCYTE HOLDINGS CORP (US) | 2025-03-19 | — | — | EP | disclosed |
| US-20250026778-A1 | GALACTOSIDE DERIVATIVE AS GALECTIN-3 INHIBITOR | TIUMBIO CO., LTD. (KR) | 2025-01-23 | — | — | US | disclosed |
| US-12201636-B2 | Heterocyclylamines as PI3K inhibitors | INCYTE CORPORATION (US) | 2025-01-21 | — | — | US | disclosed |
| US-12152033-B2 | Use of pyrazolopyrimidine derivatives for the treatment of PI3K-δ related disorders | INCYTE CORPORATION (US) | 2024-11-26 | — | — | US | disclosed |
| WO-2024151519-A2 | PPARG MODULATORS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATIN, INCORPORATED (US) | 2024-07-18 | — | — | WO | disclosed |
| US-9643984-B2 | Method for the preparation of [1,2,4]-triazolo[4,3-a]pyridines | AMGEN INC. (US) | 2017-05-09 | — | — | US | disclosed |
| US-20160347769-A1 | METHOD FOR THE PREPARATION OF [1,2,4]-TRIAZOLO[4,3-A]PYRIDINES | AMGEN INC. | 2016-12-01 | — | — | US | disclosed |
| US-20160347769-A1 | METHOD FOR THE PREPARATION OF [1,2,4]-TRIAZOLO[4,3-A]PYRIDINES | AMGEN INC. | 2016-12-01 | — | — | US | disclosed |
| EP-2751059-B1 | PROCESS FOR PREPARING DI-SUBSTITUTED SUCCINATES | SAUDI BASIC IND CORP (SA) | 2015-09-16 | — | — | EP | disclosed |
| WO-2014210042-A2 | METHOD FOR THE PREPARATION OF (1,2,4)-TRIAZOLO(4,3-A)PYRIDINES | AMGEN INC. (US) | 2014-12-31 | — | — | WO | disclosed |
| US-8889898-B2 | Process for preparing di-substituted succinates | SAUDI BASIC INDUSTRIES CORPORATION (SA) | 2014-11-18 | — | — | US | disclosed |
| US-20140194647-A1 | PROCESS FOR PREPARING DI-SUBSTITUTED SUCCINATES | SAUDI BASIC INDUSTRIES CORPORATION (SA) | 2014-07-10 | — | — | US | disclosed |
| EP-2751059-A1 | PROCESS FOR PREPARING DI-SUBSTITUTED SUCCINATES | Saudi Basic Industries Corporation (SA) | 2014-07-09 | — | — | EP | disclosed |
| WO-2013029767-A1 | PROCESS FOR PREPARING DI-SUBSTITUTED SUCCINATES | SAUDI BASIC INDUSTRIES CORPORATION (SA) | 2013-03-07 | — | — | WO | disclosed |